Smokers with CT Detected Emphysema and No Airway Obstruction Have Decreased Plasma Levels of EGF, IL-15, IL-8 and IL-1ra

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  de Torres, Juan P ^a   Blanco, David ^b   Alcaide, Ana B ^a   Seijo, Luis M ^a   Bastarrika, Gorka ^a   Pajares, María José ^b   Muñoz Barrutia, Arrate ^b   Ortiz de Solorzano, Carlos ^b   Pio, Ruben ^b   Campo, Arantza ^a   Montes, Usua ^a,b   Segura, Victor ^b   Pueyo, Jesús ^a   Montuenga, Luis M ^b   Zulueta, Javier J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 15; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOSURVEILLANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SMOKING; SPIROMETRY; THORAX RADIOGRAPHY;

CYTOKINES; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-15; INTERLEUKIN-8; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY EMPHYSEMA; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

NICOTIANA TABACUM;

EID: 84875949707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060260     Document Type: Article

References (34)

1. Hasan SU, (1996) ATS Statement-Cigarette Smoking and Health. Am J Respir Crit Care Med 154: 1579-1580.
2. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3: e442.
3. Pauwels RA, Rabe KF, (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620.
4. Madani A, Zanen J, de Maertelaer V, Gevenois PA, (2006) Pulmonary emphysema:objective quantification at multi-detector row CT-comparison with macroscopic and microscopic morphometry. Radiology 238: 1036-43.
5. de Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, et al. (2007) Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 132: 1932-8.
6. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, et al. (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 178: 738-44.
7. David H, (1988) Rudolf Virchow and modern aspects of tumor pathology. Pathol Res Pract 183: 356-364.
8. Bastarrika G, Garcia-Velloso MJ, Lozano MD, Montes U, Torre W, et al. (2005) Early Lung Cancer Detection Using Spiral Computed Tomography and Positron Emission Tomography. Am J Respir Crit Care Med 171: 1378-1383.
9. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, et al. (1999) Early Lung Cancer Action Project: Overall Design and Findings From Baseline Screening. Lancet 354: 99-105.
10. National Emphysema Treatment Trial Research Group (2001) Patients at High Risk of Death after Lung-Volume-Reduction Surgery. N Engl J Med 345: 1075-1083.
11. American Thoracic Society (1995) Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 152: S77-121.
12. Roca J, Burgos F, Sunyer J, Saez M, Chinn S, et al. (1998) References Values for Forced Spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J 11: 1354-1362.
13. Global Initiative for Chronic Obstructive Lung Disease. (2008) Global Strategy for diagnosis, managment and prevention of COPD. Available: http://www.goldcopd.org/. Accessed 2013 Mar 13.
14. Dunbar SA, (2006) Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta. 363: 71-82.
15. Chung KF, (2001) Cytokines in chronic obstructive pulmonary disease. Eur Respir J 18: 50s-59s.
16. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, et al. (2007) Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 62: 595-601.
17. WQ Gan, SFP Man, A Senthilselvan, DD Sin, (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 59: 574-80.
18. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, et al. (2006) C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 27: 902-7.
19. Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, et al. (2009) The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. 4: e6865.
20. Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, et al. (2010) Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med. 104: 275-82.
21. Smith BM, Pinto L, Ezer N, Sverzellati N, Muro S, et al. (2012) Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer. 77: 58-63.
22. Ishii M, Yamaguchi Y, Yamamoto H, Hanaoka Y, Ouchi Y, (2008) Airspace enlargement with airway cell apoptosis in klotho mice: a model of aging lung. J Gerontol A Biol Sci Med Sci. 63: 1289-98.
23. Lemos-González Y, Rodríguez-Berrocal FJ, Cordero OJ, Gómez C, Páez de la Cadena M, (2007) Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br J Cancer. 96: 1569-78.
24. Rosell R, Moran T, Queralt C, Porta R, Cardenal F, et al. (2009) Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 361: 958-67.
25. Budagian V, Bulanova E, Paus R, Bulfone-Paus S, (2006) IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17: 259-80.
26. Mian MF, Pek EA, Mossman KL, Stämpfli MR, Ashkar AA, (2009) Exposure to cigarette smoke suppresses IL-15 generation and its regulatory NK cell functions in poly I:C-augmented human PBMCs. Mol Immunol. 46: 3108-16.
27. Carbó N, López-Soriano J, Costelli P, Busquets S, Alvarez B, et al. (2000) Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br Br J Cancer. 83: 526-31.
28. Kurosaki H, Ishii T, Motohashi N, Motegi T, Yamada K, et al. (2009) Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD. Intern Med. 48: 41-8.
29. Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, et al. (2005) Role of trans-celullar IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhance tumour immunosurveillance. Blood 105: 721-7.
30. Arend WP, Malyak M, Guthridge CJ, Gabay C, (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 16: 27-55.
31. Dayer JM, (2002) Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin Exp Rheumatol. 20: S14-20.
32. Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, et al. (2002) Immune response in asymptomatic smokers. Acta Anaesthesiol Scand. 46: 959-64.
33. Sapey E, Ahmad A, Bayley D, Newbold P, Snell N, et al. (2009) Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol. 29: 508-16.
34. Lind H, Zienolddiny S, Ryberg D, Skaug V, Phillips DH, et al. (2005) Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer. 50: 285-90.